The data suggested that inhibition of store-operated Ca2+ entry can reduce myocardial hypertrophy induced by phenylephrine, which indicates that the STIM1-Orai1-Ca2+ dependent pathway is located upstream of hypertrophy [72]. Here, ORAI1 is linked to cardiac hypertrophy.